Resources

Racial and Ethnic Diversity in Pharma and Clinical Trials

Racial and Ethnic Diversity in Pharma and Clinical Trials

Fair representation of minorities across sectors is an important talking point in the diversity, equity, and inclusion narrative.

Unfortunately, racial and ethnic minorities remain starkly underrepresented in clinical trials and in the US pharma workforce.

CACTUS strongly supports inclusion and diversity and is working hard to raise awareness about this issue.

About the author

Cactus Life Sciences

Cactus Life Sciences

Cactus Life Sciences helps pharma, biotech, and medical device organizations worldwide with content strategy, development, and data. We work with medical affairs to disseminate insight-driven information to healthcare professionals, payors, and patients in a range of formats.

Leave a Comment